Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Trading Statement

9 Jul 2010 07:00

RNS Number : 0904P
Charlemagne Capital Limited
09 July 2010
 



9 July 2010

 

 

Charlemagne Capital Announces Unaudited Revenues and Assets under Management for the Six Months Ended 30 June 2010

 

 

Charlemagne Capital Limited ("Charlemagne" or the "Group") sets out below the key revenue items and Assets under Management ("AuM") for the first six months of its current financial year. It is expected that the interim financial results will be announced on 7 September 2010.

 

Key highlights and Group AuM

 

§ Group AuM US$2.8 billion in total at 30 June 2010, up by 16% on June 2009, down 9.5% since 1 January 2010.

 

§ Net management fees up 24% on same period last year and 1% on previous six months.

 

§ Overall decline in emerging markets in the first half of the year following the fall in global equities markets during the second quarter.

 

§ The Group remains well-capitalised and is continuing to invest in building the business.

 

The table below sets out the Group's AuM as at 30 June 2010 and the movements experienced in each product range in the period since 1 January 2010.

 

01-Jan-10

Net Subscriptions

Reorganisation

Net Performance

30-Jun-10

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

562

(48)

(8.5)

-

-

(39)

(7.2)

475

(15.5)

OCCO

105

60

57.1

-

-

10

7.4

175

66.7

Institutional Advisory

912

(43)

(4.7)

-

-

(75)

(8.4)

 

794

(12.9)

Institutional Mandates

1,234

(43)

(3.5)

(3)

(0.2)

(82)

(6.8)

 

1,106

(10.4)

Specialist

239

17

7.1

-

-

(45)

(18.2)

211

(11.7)

Total

3,052

(57)

(1.9)

(3)

(0.1)

(231)

(7.6)

2,761

(9.5)

 

Notes

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

 

Unaudited revenue numbers for the six months ended 30 June 2010

 

Net management fees receivable were US$10.4 million compared with US$8.4 million for the first six months of 2009, reflecting the higher average AuM in the first half of 2010.

 

Crystallised performance fees were US$3.8 million compared with US$0.3 million for the comparative period in 2009. As previously announced, US$3.7 million of crystallised performance fees received in the period relate to the distribution of the net assets of SWR Investments Limited, a jointly controlled entity now in the process of being wound up.

 

Accruing performance fees for 2010 which have not crystallised were US$2.1 million compared with US$0.9 million as at the same date in 2009. Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the Group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption. Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility.

 

Dividend

 

In the absence of unforeseen circumstances, the Group intends to declare an Ordinary and a Special Interim dividend in respect of the six months to 30 June 2010. Further details will be provided in the interim results announcement.

 

Summary

 

The period has seen declines in emerging market indices and the Group has experienced modest net outflows during the period. However it is encouraging to note that the OCCO product is attracting strong and continuing inflows and the Group has again recommenced fund raising for property (specialist) investments. Outflows within the institutional mandate category were largely caused by the enforced rebalancing of mandates and there were no client losses. In the last week of the half year, two new Magna sub funds were launched, the Undervalued Assets Fund and the Emerging Markets Dividend Fund.

 

Emerging market equities lost ground in the second quarter of this year following the recovery made in 2009 and the first quarter of 2010. The asset class as a whole lost 8% in the quarter and around 6% in the first half of the year. This is due to a combination of global and market-specific factors. Globally, fears of a broadening of the Greek sovereign crisis frightened some investors. Furthermore, investors continued to fret about the slowing Chinese economy which negatively impacted commodities markets. There is however growing evidence that the policy tightening in China is succeeding and may be coming to a close.  Charlemagne's investment performance in key areas has improved in the last twelve months and we are confident that this, together with some degree of normalisation in markets, will lead to improved business flows going forward.

 

 

Enquiries:

 

Charlemagne Capital

 

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

Lloyd Jones, Chief Financial Officer

Tel. 01624 640200

 

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

 

Gemma Froggatt

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDRXSGBGGI
Date   Source Headline
20th Jan 20219:05 amRNSSecond Price Monitoring Extn
20th Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 202110:00 amRNSIssue of Equity and Total Voting Rights
12th Jan 20218:22 amRNSTR-1: Notification of major holdings
11th Jan 20214:35 pmRNSPrice Monitoring Extension
11th Jan 202111:31 amRNSIssue of Equity and Total Voting Rights
11th Jan 20219:00 amRNSTR-1: Notification of major holdings
11th Jan 20217:00 amRNSTR-1: Notification of major holdings
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
6th Jan 20215:32 pmRNSTR-1: Notification of major holdings
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn
20th Nov 20209:00 amRNSPrice Monitoring Extension
18th Nov 20207:00 amRNSTR-1: Notification of major holdings
19th Oct 20202:41 pmRNSWarrant Update
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
6th Oct 20203:08 pmRNSNew Website
14th Dec 20164:01 pmRNSScheme Effective
13th Dec 20164:15 pmRNSCourt Sanction of Scheme
13th Dec 20167:30 amRNSSuspension - Charlemagne Capital Limited
12th Dec 20168:05 amRNSDocument re: Charlemagne Capital
12th Dec 20168:01 amRNSSuspension of Dealings and Transfers
9th Dec 201610:55 amRNSDocument re: Charlemagne Capital
8th Dec 20161:22 pmRNSConfirmation of Regulatory Clearance
8th Dec 201611:36 amRNSDocument re: Charlemagne Capital
7th Dec 20164:25 pmRNSDocument re: Charlemagne Capital
7th Dec 20164:21 pmRNSDocument re: Charlemagne Capital
2nd Dec 20165:19 pmRNSResults of the Court Meeting
10th Nov 20167:00 amRNSScheme Circular
14th Oct 20163:05 pmRNSDocument re: Charlemagne Capital
12th Oct 20167:00 amRNSQ3 2016 AUM Update
3rd Oct 20163:30 pmRNSTR-1: Notification of Major Interest in Shares
30th Sep 20163:01 pmRNSOPD - Charlemagne Capital - Replacement
30th Sep 20162:50 pmRNSDoc re. Charlemagne Capital
30th Sep 20167:00 amRNSForm 8 (OPD) Charlemagne Capital plc
30th Sep 20167:00 amRNSRecommended Cash Offer for Charlemagne
30th Sep 20167:00 amRNSHalf Yearly Report
19th Sep 201611:01 amRNSTR-1: Notification of Major Interest in Shares
14th Jul 20167:00 amRNSTrading Statement
27th Jun 20164:40 pmRNSSecond Price Monitoring Extn
27th Jun 20164:35 pmRNSPrice Monitoring Extension
17th Jun 20161:56 pmRNSResult of AGM
20th May 20164:38 pmRNSAnnual Report and Notice of AGM
28th Apr 20161:22 pmRNSTR-1: Notification of Major Interest in Shares
15th Apr 201610:08 amRNSTR-1: Notification of Major Interest in Shares
11th Apr 20167:00 amRNSQ1 2016 AUM Update
24th Mar 20169:16 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.